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Ventricular dysfunction induced by dipyridamole would be 
evidence of myocardial ischemia in patients with limited 
ability to undergo standard exercise testing. Radionuclide 
ventriculography before and after intravenous dipyridam- 
ole infusion was compared with the results of exercise 
radionuclide ventriculography in a prospective study of 31 
patients undergoing coronary angiography. Among these 
patients, 21 (68%) had significant coronary artery disease 
(~50% stenosis), 19 (61%) had severe coronary disease 
(~-70% stenosis) and 10 (32%) were “normal” (<SO% 
stenosis). The left ventricular ejection fraction was calcu- 
lated, and regional wall motion was scored on a 6 unit scale. 
In the normal patients, the ejection fraction (2 SEM) 
increased 5.6 + 2% (units) during exercise and 7.9 + 1 
units after dipyridamole (both p 5 0.004 compared with 
that during rest). However, in patients with coronary 
artery disease, the ejection fraction failed to increase dur- 
ing exercise or after dipyridamole. In the patients with 
coronary artery disease, regional wall motion decreased by 
4.1 -t 0.5 units during exercise (p < 0.003) and by 1.8 units 
after dipyridamole (p < 0.02). Receiver operating charac- 
teristic analysis demonstrated general comparability be- 
Scintigraphic exercise testing is more sensitive than standard 
electrocardiographic exercise testing for detecting myocar- 
dial ischemia (l-3). Dipyridamole has been used to produce 
coronary vasodilation (C7), thus permitting scintigraphic 
imaging of inhomogeneous myocardial perfusion (5,&l&12) 
in patients with limited exercise tolerance. Dipyridamole 
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tween the sensitivity and specificity of exercise and dipyri- 
damole ventriculography, with “optimal” operating points 
that favored choosing high sensitivity for the former and 
high specificity for the latter. Specific subsets of patients 
with severe coronary atherosclerosis were analyzed with 
use of these criteria. In patients with severe stenosis 
(>70%), the sensitivity of dipyridamole ventriculography 
was 67% compared with 89% for exercise ventriculogra- 
phy. However, at these levels of sensitivity, the specificity of 
dipyridamole ventriculography was 92% compared with 
67% for exercise ventriculography. In this and other sub- 
sets of patients, the specificity of dipyridamole ventriculog 
raphy exceeded that of exercise ventriculography. 
Thus, it is concluded that dipyridamole radionuclide 
ventriculography is moderately sensltive and highly specific 
for detecting severe coronary atherosclerosis. This tech- 
nique provides a widely applicable, useful alternative to 
exercise ventriculography in the diagnosis of coronary 
atherosclerosis in patients who have limited exercise toler- 
ance. 
(J Am CON Cardiol 1989;13:841-51) 
thallium imaging correlates with significant coronary steno- 
sis (8-12) and has identified high risk patients, both before 
peripheral vascular surgery (13) and after acute myocardial 
infarction (14). Although dipyridamole may produce malper- 
fusion, not all malperfusion produces ischemia. We reasoned 
that new left ventricular wall motion abnormalities would 
indicate myocardial ischemia more definitely than would 
malperfusion alone. Echocardiography can demonstrate 
dipyridamole-induced regional wall motion abnormalities 
(15-19); however, echocardiography is limited by imaging 
difficulties (18,19). The purpose of this study was to establish 
the sensitivity and specificity of dipyridamole radionuclide 
ventriculography for detecting myocardial ischemia in a 
group of patients with documented coronary anatomy, and 
to compare the results with those of standard exercise 
radionuclide ventriculography. 
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Figure 1. Protocol for exercise and dipyridamole radionuclide ven- 
triculography (RVG). IV = intravenous. 
Methods 
Study patients. We evaluated 31 consecutive patients 
undergoing diagnostic coronary arteriography for a stable 
chest pain syndrome from August 1986 to November 1987. 
Patients were prospectively enrolled if they were to undergo 
cardiac catheterization, were able to exercise and if their 
clinical status permitted performing exercise and dipyridam- 
ole radionuclide ventriculography. We excluded patients 
who had prior Q wave myocardial infarction, prior coronary 
artery bypass surgery or significant uncontrolled ventricular 
arrhythmia or who were being treated with xanthines for 
obstructive pulmonary disease. Informed consent was ob- 
tained on forms approved by the Vanderbilt Committee for 
the Protection of Human Subjects. The study group con- 
sisted of 26 men and 5 women aged 41 to 74 years (mean 60). 
Twenty-six patients were receiving a nitrate, a beta-adren- 
ergic receptor antagonist or a calcium channel blocking drug 
alone or in combination. All patients underwent imaging and 
catheterization within 14 days. 
Data Acquisition 
Cardiac catheterization. Multiple views of the right and 
left coronary arteries were obtained with the Seldinger 
technique. 
Exercise radionuclide ventriculography. The fasting su- 
pine patients underwent both exercise and dipyridamole 
radionuclide ventriculography under the protocol shown in 
Figure 1. Red blood cells were labeled in vivo by injection of 
1.5 mg stannous pyrophosphate, followed by 25 to 30 mCi 
technetium-99m pertechnetate (20). For each stage, electro- 
cardiographically gated images were collected with the pa- 
tient at supine rest with the legs slightly elevated in the 
pedals of a bicycle ergometer (Collins). Images were ob- 
tained in both the anterior view and the left anterior oblique 
projection that optimized separation of the ventricles with 
use of a gamma camera (LEM, Siemens) equipped with a 
low energy all-purpose collimator, employing the 140 keV 
energy peak with a 20% window, and collecting at least 1.5 
million counts/image. Data were stored in a computer (model 
1 l/34, Digital Equipment) in a 64 x 64 matrix, with 30 to 40 
ms/frame and 20 frames/cardiac cycle. 
Exercise was performed with the patient supine using a 
single stage maximal exercise protocol, pedaling the ergo- 
meter at 60 rpm, initially at a minimal work load of 25 W, 
then increasing to the maximal work load that each patient 
could maintain during two consecutive 3 min image collec- 
tions, first in the left anterior oblique projection, then in the 
anterior view. The Frank electrocardiographic (ECG) leads 
X, Y and Z, cuff blood pressure and heart rate were recorded 
at baseline and every minute during exercise and recovery. 
Dipyridamole radionuclide ventriculography. A rest pe- 
riod of 30 min was allowed after exercise to allow heart rate 
and blood pressure to return to baseline. A second set of rest 
images was obtained using the methods just noted. Dipyri- 
damole (supplied by Alan Ranhosky, MD, Boehringer- 
Ingelheim Pharmaceuticals, Inc.) was infused through a 20 
gauge intravenous cannula into an antecubital vein at a rate 
of 0.14 mg/kg body weight per min over 4 min (0.56 mg/kg), 
followed by 0.165 mglkg over the next 2 min period, for a 
total dose of 0.725 mglkg. After 2 min of equilibration, a 
repeat set of left anterior oblique and anterior images was 
collected. Blood pressure, heart rate and ECG were re- 
corded at 1 min intervals for the first 15 min after the start of 
the infusion. 
Data Analysis 
Coronary angiography. Coronary arteriograms were an- 
alyzed by consensus of two trained observers who did not 
know the scintigraphic results. The location and percent 
diameter narrowing of each coronary lesion were recorded. 
Rare differences of opinion were resolved by a third trained 
observer who had no clinical or scintigraphic information. 
“Significant” coronary artery disease was defined as a 
stenosis rSO%, and “severe” coronary artery disease was 
defined as a stenosis 270% in one or more of the major 
vessels in one angiographic projection. Patients were cate- 
gorized by the specific vessels affected and by the categories 
“significant” and “severe” coronary atherosclerosis. Pa- 
tients were defined as “normal” if they had no evidence of 
~50% stenosis in any major coronary artery or branch. 
Radionuclide ventriculography. The left ventricular ejec- 
tion fraction was calculated with use of software validated in 
our laboratory (21). For analyzing regional wall motion, 
playback buffers were constructed with rest images on the 
left and exercise or dipyridamole images on the right. All 
images were analyzed by three observers who were unaware 
of patient identification, cardiac catheterization information 
and whether the images represented the exercise or dipyri- 
damole tests. For analyzing regional wall motion (Fig. 2), 
each segment of the moving exercise or dipyridamole images 
was graded with use of a 6 point scale: 4 = hyperkinetic; 3 = 
normal; 2 = mildly hypokinetic; 1 = severely hypokinetic; 0 
= akinetic; - 1 = dyskinetic, allowing l/2 point gradations. 
The analogous segments were compared at rest and during 
exercise or after dipyridamole infusion. All changes in 
regional wall motion with exercise or after dipyridamole 
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criteria ,for detecting coronuty atherosclerosis were culcu- 
loted nccording to the following equrrtions: 
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Figure 2. Method for wall motion analysis. Region wall motion was 
scored in each of nine left ventricular (LV) segments. See text for 
details. 
were recorded. The maximal decrease in wall motion in any 
segment and the total algebraic reduction in wall motion 
score were recorded. 
Statistical analysis. The mean 2 SEM for blood pressure. 
hea\rt rate, left ventricular ejection fraction and wall motion 
at rest, during exercise, during the second rest period and 
after dipyridamole were calculated for the normal group, the 
abnormal group and subsets of the abnormal group. Each of 
these variables was evaluated by one-way analysis of vari- 
ance and then by paired and unpaired t tests if the analysis of 
variance showed significant differences. Statistically signifi- 
cant differences were defined at p < 0.05. 
Ejection fraction and regional wall motion data were also 
evaluated by receiver opertrting characteristic analysis (22). 
By this method, it was possible to test numerous scinti- 
graphic criteria for defining a positive test, and establish 
their sensitivity and specificity. For each of the criteria, the 
true positive fraction (sensitivity) was compared with the 
false positive fraction (I - specificity) by plotting their 
coordinates and numbering the points. Smooth curves were 
drawn through the data points to allow visual comparison of 
the performance of both tests. “Optimal” operating charac- 
teristics were selected by inspection of the data. These 
characteristics favored high sensitivity for exercise ventric- 
ulography and high specificity for dipyridamole ventriculog- 
raphy (see Results). The criteria that corresponded to the 
optimal operating characteristic for dipyridamole were de- 
fined for both ejection fraction and regional wall motion. 
These criteria wjere then applied to exercise ventriculogra- 
phy. If there was an obvious improvement in sensitivity and 
specificity by choosing other criteria for exercise ventricu- 
lography, those criteria were employed instead. Finally, the 
optimal criteria for each test were applied to specific subsets 
of the abnormal group with more severe degrees of coronary 
artery disease. 
Sensitivity = true positives/[true positives t false negatives] 
Specificity = true negatives/[false positives t true negatives] 
Predictive value (+) = true positives/[true positives + false 
positives] 
Predictive value t-j = true negatives/[false negatives t true 
negatives] 
Results 
Patient groups. Table 1 lists the distribution of coronary 
atherosclerosis in the study group. By our criteria, 10 
patients (32%) were categorized as normal (defined as ~50% 
stenosis): this group had no lesions with >30% luminal 
narrowing. Twenty-one patients (68%) had significant coro- 
nary atherosclerosis (at least one vessel having ~-50% ste- 
nosis), and 19 (61%) had severe coronary atherosclerosis 
(~70% stenosis). Further subsets of coronary atherosclero- 
sis are listed on the basis of the presence of a specific 
abnormality, but possibly including other abnormalities. 
Thus, 250% stenosis in one vessel includes all abnormal 
patients listed in the other more circumscribed subsets. 
Hemodynamics. During exercise. mean (ISEM) heart 
rate increased from 70 2 10 to 120 i 19 beatslmin (p < 
0.0001). and systolic blood pressure increased from 137 +- 20 
to 185 + 24 mm Hg (p < 0.0001). After dipyridamole 
infusion, heart rate increased from 74 2 Ii to 93 2 14 beats/ 
min (p < 0.0001). and systolic blood pressure decreased 
from 137 +- 20 to 118 + 18 mm Hg (p < 0.0001). The 
rate-pressure product was 22,171 ? 5,187 (beatsimin x mm 
Hg) at peak exercise; after dipyridamole infusion it was 
significantly lower (10,997 I 2,283; p < 0.001). 
Symptoms and ECG during dipyridamole and exercise 
testing. Ischemic chest discomfort occurred in approxi- 
mately one-third of the patients, with similar sensitivity and 
specificity for the presence of coronary stenosis between the 
two tests (Table 2). For patients with severe coronary 
Table 1. Distribution of Coronary Atherosclerosis in 3 I Patients 
The sensitivity, spec$city and predictive value of the 
CAD (% stenosis) No. % 
?I VDz50% ?I 68 
~1 VDz70R I9 61 
22 VD 2 50% IX 58 
2 VD 2 70% I4 45 
3 VD I 50% I? 39 
3 VD 2 70% 4 13 
LAD 2 70% II 39 
LM 2 50% ? 6 
“Normal” IO 32 
Total 31 100 
CAD = coronary atherosclerotic disease; LAD = left anterior descending 
coronary artery: LM = left main coronary artery; No. = number of patients; 
“Normal” = “insignificant” (<50%) stenosis; VD = vessel disease. 
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Table 2. Symptoms and Electrocardiographic Results in 
31 Patients 
Chest Pain ST Segment Depression 
Sensitivity (%)/ Sensitivity (%I/ 
No. % Specificitv (%%) No. % Soecificitv (%l 
Dipyridamole 
ventriculography 
CAD 2 70 7 37 37166 5 26 261100 
(n = 19) 
CAD 2 50 8 38 38170 5 24 241100 
(n = 21) 
No CAD 3 30 0 0 
(n = IO) 
Exercise 
ventriculography 
CAD 2 70 6 32 32166 10 53 53158 
(n = 19) 
CAD 2 50 7 33 33170 II 52 52160 
(n = 21) 
No CAD 3 30 4 40 
(n = 10) 
CAD = coronary artery disease; No. = number of positive tests. 
disease, ST segment depression diagnostic of ischemia was 
more common during exercise (53%) than during dipyridam- 
ole infusion (26%). However, the specificity of this sign was 
100% during dipyridamole infusion, but only 58% during 
exercise. Side effects of dipyridamole were frequent, but 
were usually mild and well tolerated. They included head- 
ache, nausea, abdominal discomfort, dizziness and flushing. 
Three patients had chest pain with ST segment depression 
and were given intravenous aminophylline, with prompt 
resolution of these findings. In each case, aminophylline was 
injected after imaging. 
Scintigraphic signs of ischemia. Scintigraphic data were 
interpretable in all patients. Figure 3 demonstrates ventricu- 
lograms at rest and during exercise compared with those 
before and after dipyridamole infusion in a typical patient 
with severe coronary atherosclerosis. Similar wall motion 
abnormalities occurred during both tests, although the ab- 
normality was quantitatively greater during exercise. 
For the entire group of patients, the analysis of ejection 
fraction after dipyridamole included only 30 patients, whereas 
the regional wall motion analysis included all 31 patients. 
There is one less ejection fraction result because in one 
patient, the left anterior oblique image after dipyridamole was 
lost as a result of computer error, but the paired anterior view 
was available for regional wall motion analysis. 
Figure 4 shows the change in left ventricular ejection 
fraction during exercise or after dipyridatnole in the normal 
patients, the entire group of abnormal patients with signifi- 
cant coronary stenosis and subsets of patients with coronary 
artery disease. Normal patients showed a significant in- 
crease in global left ventricular ejection fraction compared 
with rest, both during exercise (+5.6 k 1.5 units; p = 0.004) 
ANT 
LAO LA@ 
REST EXERClX REST OlPYRlOAMOLE 
Figure 3. Left ventricular dysfunction during radionuclide ventric- 
ulography (RVG) during exercise and after dipyridamole infusion. 
Representative scintigraphic data from a patient with severe three 
vessel coronary atherosclerosis. Top, End-systolic frames in ante- 
rior (ANT) and left anterior oblique (LAO) views show marked left 
ventricular dilation during exercise and after dipyridamole. Middle, 
Traced end-diastolic and end-systolic outlines demonstrate similar 
degrees of left ventricular dilation and regional hypokinesia during 
both tests. Dysfunction was greatest in the interventricular septum, 
apex and anterior wall. Bottom, Changes in systolic blood pressure 
(SBP), heart rate (HR) and ejection fraction (EF) and the decrease in 
regional wall motion (DRWM). There were marked differences in 
systolic blood pressure and heart rate during exercise compared 
with dipyridamole, but similar left ventricular dysfunction, demon- 
strated by a decrease in regional wall motion score and a reduced 
ejection fraction. 
or after dipyridamole (+7.9 k 1.0 units; p = 0.001). In 
contrast, in patients with coronary artery disease, the ejec- 
tion fraction failed to increase during exercise or after 
dipyridamole compared with rest. There was a trend toward 
a progressive decrease from ‘Kk baseline ejection fraction 
with increasing severity of disease, although this was not 
usually statistically significant. However, when compared 
with the normal response, this abnormality in ejection frac- 
tion response was highly significant in nearly all cases. 
Figure 5 shows the total decrease in wall motion scores 
during exercise and after dipyridamole in the same format as 
Figure 4. During exercise, normal subjects sometimes ap- 
peared to have a small but significant (p < 0.05) reduction in 
regional wall motion, which averaged 0.75 unit compared 
with rest. The abnormal group had much greater reductions 
in wall motion (average 4.1 units; p < 0.001). After dipyri- 
damole, there was no significant decrease in wall motion in 
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Figure 4. Changes in left ventricular ejec- 
tion fraction with exercise or dipyridamole 
radionuclide ventriculography (RVG). The 
change in ejection fraction from the rest 
state in 10 normal patients is compared with 
the change in 21 abnormal patients and the 
subsets of these 2 I patients with significant 
or severe coronary stenosis. Normal pa- 
tients show a significant increase in ejection 
fraction on both tests. The ejection fraction 
response was blunted with increasing sever- 
ity or coronary disease. The column labels 
indicate one, two or three vessel disease 
(VD) with 90% or ~70% stenosis. LAD = 
left anterior descending coronary artery: 
LM = left main coronary artery. 
*NORMAf’ zlVD50 21VD70 22VD50 z2VD70 3VD>50 3VD?70 &AD70 3VDL70 zLAD70 
WO) +LM *LM 
19 18 14 12 4 12 
t+ + + 
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I 
+ 
u 1 MEAN ? SEM * 
-15 0 EXERCISE RVG 
m DIPYRIDAMOLE RVG 
the normal patients. However, in the abnormal group and in 
most of its subsets, there was a significant decrease in wall 
motion score during exercise or after dipyridamole. These 
changes were significant when compared with rest and with 
the normal response. Exercise elicited larger ischemic re- 
sponses in wall motion (Fig. 5) and ejection fraction (Fig. 4) 
than did dipyridamole, although the changes were highly 
significant for both tests. 
Table 3 and Figure 6 demonstrate recei\ver operating 
characteristic analysis of changes in ejection fraction and 
regional wall motion divided by severity of coronary athero- 
sclerosis during dipyridamole and exercise ventriculogra- 
phy. Figures 6A and B demonstrate the ejection fraction 
results. There was a general similarity between the exercise 
and dipyridamole curves, but they diverged in the region of 
high specificity, where dipyridamole ventriculography ap- 
peared superior when specificity was 290%. Conversely. 
Figure 5. Total decrease in regional wall mo- 
tion score with exercise or dipyridamole 
radionuclide ventriculography (RVG). Nor- 
mal patients had no significant decrease in 
wall motion from the resting state after dipyr- 
idamole and a minimal decrease during exer- 
cise. Patients with significant coronary steno- 
ses had a marked decrease in wall motion on 
both tests. See text for details. Format and 
abbreviations as in Figure 4. 
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% 
3 *+ 
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* -0.005<p”O.O5 vs BASELINE ++ pcO.001 vs NORMAL 
17 -EXERCISE RVG 
??- DIPYRIDAMOLE RVG 
f -MEAN +SEM 
14 
T ++ * ++ 
exercise ventriculography was slightly more sensitive for 
detecting coronary atherosclerosis when specificity criteria 
were relaxed. Failure to increase ejection fraction by 24% 
(units) defined the highest sensitivity for dipyridamole ven- 
triculography when specificity of 290% was desired (point 
8). The same criterion applied to exercise ventriculography 
achieved higher sensitivity but with lower specificity (point 
IO). However. point I I (failure to increase ejection fraction 
by ~5% [units]) would be more useful because sensitivity 
increased to 86% (Fig. 6A) and 89% (Fig. 6B) with no decline 
in specificity. This criterion was later applied to other patient 
subsets (Fig. 7). 
Figures 6C and D demonstrute N similar mnalysis by 
maximcrl changes in regional ~~11 motion. There was a 
general similarity between the curves, but they crossed, and 
dipyridamole ventriculography was approximately as sensi- 
tive and was more specific than exercise ventriculography 
c 
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Table 3. Receiver Operating Characteristic Analysis 
Dipyridamole Radionuclide Ventriculography Exercise Radionuclide Ventriculography 
?I VD ~50% ?I VD ~70% ?I VD 250% 21 VD ~70% 
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity 
Criterion for Positive Test No. (%I (%I (%I (%I No. (%I (%I (%I (%I 
Ejection fraction 
Decrease 
>8 I 10 100 II 100 I 33 100 32 92 
28 - - - 2 43 100 42 92 
27 - - - - - - - - 
S6 - - - - - - - - 
25 2 I5 100 17 100 - - - - 
24 3 20 100 22 100 3 52 100 53 92 
23 4 25 100 28 100 4 57 90 58 83 
22 - - - - 5 62 90 63 83 
21 5 35 100 41 10 6 62 80 63 75 
Decrease or no change 6 45 100 50 100 7 67 80 68 75 
Failure to increase 
22 7 55 100 56 92 8 71 80 74 75 
23 - - - 9 76 80 79 75 
24 8* 65 100 67 92 IO 76 70 79 67 
25 9 70 70 72 67 II 86 70 89 67 
26 r - - - - I2 90 60 95 58 
27 10 80 60 83 58 - - - 
28 II 85 50 89 50 I3 90 40 95 42 
29 I2 90 50 94 42 I4 90 30 95 33 
Maximal change in regional wall 
motion (units) 
Decrease 
22 - - - - I IO 100 II 100 
21.5 I 14 100 16 100 2 I9 90 21 92 
21.0 2 29 100 32 100 3 62 70 63 67 
20.5 3* 52 90 58 92 4 90 40 95 42 
Decrease or no change 4 90 50 90 42 5 9s 30 95 25 
Failure to increase 
Sl 5 90 IO 90 8 6 9s IO 95 8 
21.5 - - - 7 95 0 95 0 
Total decrease in regional wall 
motion (units) 
~8.0 1 10 100 II loo I I9 IO0 21 100 
27.5 - - - - - - - - 
27.0 - - - - - - - - 
26.5 - - - 2 24 100 26 100 
~6.0 2 I4 100 I6 100 3 29 100 32 100 
25.5 - - - - - - - 
25.0 3 19 100 21 100 - - - - 
24.5 - - - - 4 38 100 42 100 
24.0 - - - - - - - 
23.5 - - - - 5 52 100 53 92 + 
23.0 4 24 100 26 100 6 62 90 63 83 
~2.5 - - - - 7 67 90 68 83 
22.0 - - - - - - - - 
21.5 5 29 100 32 100 8 81 70 84 67 
z1.0 6 33 100 37 ItXl 9 86 70 90 67 
20.5 7* 52 90 58 92 IO 91 40 95 42 
*“Optimal” operating point for dipyridamole ventriculography (see Fig. 6). No. = point number in Figure 6; 21 VD ~50% = coronary stenosis ~50% in at 
least one vessel; 2 I VD 270% = coronary stenosis ~70% in at least one vessel. 
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Figure 6. Receiver operating characteristic analysis. 
Each panel compares sensitivity (true positive traction) 
and specificity (1 - false positive fraction) for exercise 
and dipyridamole radionuclide ventriculography (RVG). 
Left panels (A, C and E) display results for patients with 
at least one vessel stenosis of ~50%. Right panels (B, D 
and F) display results for patients with at least one 
vessel stenosis of -70%. A and B = ejection fraction: C 
and D = the maximal decrease in wall motion in any 
region: E and F = total decrease in regional wall motion 
score. The test criteria for numbered points are listed in 
Table 3. The thick solid arrow in each panel denotes the 
point chosen for “optimal” sensitivity and specificity of 
dipyridamole ventriculography. The thin solid arrow in 
each panel marks the same criterion applied to exercise 
ventriculography. The thick open arrow indicates the 
point chosen for “optimal” sensitivity and specifity of 
exercise ventriculography. See text for details. 
2 1 VESSEL 
50% STENOSIS 
when criteria for high specificity were stipulated. For dipyr- 
idamole ventriculography, any reduction in wall motion 
(~0.5 unit) was highly specific for the presence of coronary 
atherosclerosis. The same criterion applied to exercise ven- 
triculography yielded a sensitivity of r90%, but specificity 
declined sharply. Point 3 in Figure 6C and D (a decrease of 
rl unit) would be considerably more specific, although with 
a decline in sensitivity. This criterion was later applied to 
other patient subsets (Fig. 7). 
Figures 6E and F demonstrate decreases in regional wall 
motion with use of the algebraic sum of the changes, 
combining all regions for each patient. Eight patients had an 
increase in score in some regions and a decline in score in 
others. The other 23 patients had uniform increases or 
decreases. The curves were generally similar, but exercise 
ventriculography was somewhat more sensitive and specific 
than dipyridamole ventriculography for detecting 250% 
i__l _-.L 
025 05 075 I@ 
~1 VESSEL 
70% STENOSIS 
U DIPVRIDAMOLE RVG 
=--- FYERCiSE RVG 
I 
0 ---0W 025 IO 
FALSE POSITIVE FRACTION 
stenosis, although not ~70% stenosis. Again, any decrease 
of ~0.5 unit in total wall motion score allowed the maximal 
sensitivity for dipyridamole ventriculography, while pre- 
serving specificity at ~90%. The same criterion applied to 
exercise ventriculography yielded sensitivity of r91%, but 
very low specificity. Point 9 in Figures 6E and F (a decrease 
of z-1 unit) was much more specific, with only a slight 
decrease in sensitivity. 
Figure 7 demonstrates the sensitivit? and specificity of 
exercise and dipyridamole ventriculography for detecting 
various degrees of coronary atherosclerosis. In each panel, 
exercise and dipyridamole ventriculography are compared 
with use of the “optimal” criteria established in the preced- 
ing discussion. In general, the sensitivity of exercise ventric- 
ulography exceeded that of dipyridamole ventriculography. 
However, the specificity of dipyridamole ventriculography 
exceeded that of exercise ventriculography for the subsets of 
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coronary lesions 250%, coronary lesions r70%, severe 
three vessel or left main coronary stenosis and severe left 
anterior descending or left main coronary artery stenosis. In 
addition, the sensitivity of dipyridamole ventriculography 
approached that of exercise ventriculography in the most 
severe categories of coronary atherosclerosis (Fig. 7, C and 
D). 
The predictive value of exercise and dipyridamole ven- 
triculography for the subsets of Figure 7 is listed in Table 4. 
The positive predictive value of dipyridamole ventriculogra- 
phy exceeded that of exercise ventriculography in nearly 
Table 4. Predictive Value in Subsets of Coronary Artery Stenosis 
Figure 7. Sensitivity and specificity of 
ejection fraction (EF) and regional wall 
motion (RWM) for detecting coronary ath- 
erosclerosis on exercise and dipyridamole 
radionuclide ventriculography (RVG). A, 
Patients with at least one significant steno- 
sis (~50%). B, Patients with at least one 
severe stenosis (270%). C, Patients with 
three vessel severe stenosis or left main 
coronary artery stenosis (30%). D, Pa- 
tients with severe stenosis of the left ante- 
rior descending coronary artery or left 
main coronary artery stenosis. Open bats 
= exercise radionuclide ventriculography; 
hatched bars = dipyridamole radionuclide 
ventriculography. (See text for details.) 
every case. The negative predictive value was generally 
comparable between the tests. In the restrictive category of 
severe three vessel stenosis, the predictive value of a posi- 
tive test was relatively low for both exercise and dipyridam- 
ole ventriculography because such positive tests could occur 
with less severe coronary stenosis. 
Discussion 
Dipyridamole versus exercise ventriculography. This 
study demonstrated that dipyridamole radionuclide ventric- 
3 VD ~70% LAD ~70% 
21 VD 250% >I VD ~70% LM ~50% LM ~50% 
EF RWM EF RWM EF RWM EF RWM 
(%i) (%J (%‘o) (%) (%) (%J (%) (%J 
Dipyridamole ventriculography 
+ Predictive value 
- Predictive value 
Exercise ventriculography 
t Predictive value 
- Predictive value 
100 92 92 92 46 33 85 75 
59 47 65 58 100 89 88 74 
86 81 81 75 29 38 57 63 
70 47 80 53 100 100 80 73 
EF = abnormal ejection fraction response; RWM = abnormal regional wall motion response: t = positive: - = negative; other abbreviations as in 
Table 1. 
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ulography compared favorably with exercise radionuclide 
ventriculography in detecting ventricular dysfunction caused 
by coronary atherosclerosis in patients with chest pain and 
no prior transmural myocardial infarction. Receiver operat- 
ing characteristic analysis demonstrated the comparability of 
these tests and revealed the “optimal” operating point for 
each. Because the curves diverged in the region of high 
specificity, it was advantageous to operate in this region 
when using dipyridamole ventriculography and in a region of 
high sensitivity when using exercise ventriculography. When 
these “optimal” criteria were applied to subsets of patients 
with severe coronary atherosclerosis, the sensitivity of di- 
pyridamole ventriculography approached that of exercise 
ventriculography. In every case, the specificity of dipyrida- 
mole testing exceeded that of exercise testing. 
Effects of dipyridamole. Dipyridamole blocks the uptake 
and degradation of adenosine by red blood cells and endo- 
thelial cells (23,24) and, thus, can increase available adeno- 
sine, which is a potent coronary vasodilator (25). In dogs, 
this vasodilation considerably increases the flow to myocar- 
dial regions without coronary stenosis, moderately increases 
the flow to regions with mild stenosis and somewhat de- 
creases the flow to regions with moderate and severe steno- 
sis (7,26). Similarly, dipyridamole increases flow to normal 
regions and decreases flow to some abnormal regions in 
patients with coronary atherosclerosis (6). Thus, dipyridam- 
ole can produce inhomogeneities in myocardial blood flow at 
rest. Such a redistribution can shunt blood from regions 
supplied by stenotic arteries to regions supplied by normal 
arteries, reducing the flow to the former (the so-called 
coronary steal phenomenon) (26-28). Several studies (5,7. 
IO,1 I) have shown a decrease in systemic arterial blood 
pressure and an increase in heart rate after dipyridamole 
infusion. The present study demonstrates similar findings 
and an increase in left ventricular ejection fraction in the 
normal subjects. All these results are consistent with a 
systemic vasodilator effect of dipyridamole. 
Myocardial perfusion imaging after dipyridamole. Several 
studies (4.5,8.11) demonstrated the usefulness of myocardial 
perfusion imaging to detect differences in flow induced by 
dipyridamole. Clinical studies (29) with thallium imaging 
after intravenous and oral dipyridamole demonstrated good 
sensitivity (range 67% to 95%) and specificity (range 67% to 
100%) for detecting malperfusion resulting from significant 
coronary stenosis. This method has been applied success- 
fully in patients who cannot exercise (29). high risk patients 
before peripheral vascular surgery (13) and patients after 
acute myocardial infarction i 14). 
Dipyridamole-induced wall motion abnormalities. Be- 
cause malperfusion may not always represent myocardial 
ischemia (4). we and others (15-17) reasoned that dipyridam- 
ole-induced regional wall motion abnormalities might be 
detectable, highly specific indicators of ischemia. Recent 
studies (15-17) showed that dipyridamole echocardiography 
is useful in localizing coronary artery lesions and has higher 
specificity than does standard exercise testing for detecting 
coronary atherosclerosis. However, the clinical applicability 
of dipyridamole echocardiography is limited by technically 
inadequate echocardiograms in approximately 20% of pa- 
tients (15.16,18,19). In contrast, high quality radionuclide 
ventriculograms can be obtained in virtually all patients. 
Radionuclide ventriculograpby after dipyridamole. There 
are few data regarding the usefulness of dipyridamole radio- 
nuclide ventriculography for detecting ischemia due to cor- 
onary stenosis. Studies (30,3l) have demonstrated a lower 
sensitivity compared with thallium imaging (13% and 31%, 
respectively) than we found, but showed a similar high 
specificity. Diflerences in methods and patient groups could 
account for the discrepancy in sensitivity. The former stud- 
ies utilized a lower dipyridamole dose than we used, and 
analyzed only a single left anterior oblique projection instead 
of the two views we employed. Also, Sochor et al. (3 1) used 
a more stringent definition for an abnormal ejection fraction 
response to dipyridamole. requiring a decrease of ~8 units. 
We found that a failure to increase by ~-4 units was the best 
“cut point” in our study patients (Table 3. Fig. 6). In the 
study of Harris et al. (30), 7 of 15 patients had wall motion 
abnormalities at rest and only two others had new wall 
motion abnormalities, yielding a sensitivity of 13%. In con- 
trast, we examined patients without prior Q wave infarction 
who were not expected to have wall motion abnormalities at 
rest. We found a much higher sensitivity in detecting signif- 
icant or severe coronary atherosclerosis by wall motion 
analysis (52 and 587~~ respectively) than did the prior report. 
The specificity of these data was ~90%. Sochor et al. (31) 
assessed the sensitivity for detecting abnormalities in a 
subset of IO patients with ~70% stenosis of the left anterior 
descending coronary artery. Six of their 10 patients devel- 
oped septal wall motion abnormalities on a single oblique 
view after dipyridamole infusion. Their sensitivity (60%) is 
comparable with our results (71%) in this specific subset of 
patients. We demonstrated previously (32) that radionuclide 
ventriculography in two views was more sensitive than was 
a single oblique view in detecting myocardial ischemia and 
assessing the functional improvement after coronary artery 
bypass. and this may be the reason for the slightly greater 
sensitivity in the present study. 
Receiver operating characteristic analysis. This method 
afforded two important advantages (22). First, it allowed the 
broad systematic application of numerous possible diagnos- 
tic criteria for defining “positive” responses for a new test, 
namely, dipyridamole radionuclide ventriculography. Sec- 
ond. it allowed a general comparison of the performance of 
this newer test to a more standardized test (that is, exercise 
radionuclide ventriculography) over a broad range of sensi- 
tivity and specificity levels. 
The dipyridamole and exercise ventriculography curves 
were generally comparable and showed the utility of dipyri- 
damole ventriculography in this group of patients. Also. 
there appeared to be a potential advantage of dipyridamole 
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ventriculography over exercise ventriculography when high 
specificity (~90%) was the goal. This advantage held true for 
ejection fraction criteria and for the maximal decrease in 
wall motion, especially in patients with severe coronary 
atherosclerosis. A limitation of this analytic method is the 
usual inability to define the criteria that correspond to the 
points on the graph. To overcome this problem, we supplied 
a table with numbered points corresponding to numbered 
data in the graph that should facilitate the use of each test by 
others. 
Several approaches have been used to analyze the dif- 
ferences among receiver operating curves, and the area 
under each curve is a relatively simple, accepted measure 
(22,33,34). The dipyridamole and exercise areas were 
roughly similar, but because the curves usually crossed, 
there was an advantage in the dipyridamole method when 
high specificity was desired and a slight advantage for 
exercise ventriculography when high sensitivity was desired. 
A single prior study (35) employed receiver operating char- 
acteristic analysis to analyze dipyridamole thallium data. 
The present study seems to be the first to apply this method 
to dipyridamole ventriculography. 
Advantages and limitations of study design. The study 
patients, dose of dipyridamole and imaging technique were 
potential limitations in the interpretation of our data. 
Study patients. The object of selecting patients as we did 
was to assess the possibility of diagnosing myocardial isch- 
emia in patients with chest pain. These patients were re- 
ferred for cardiac catheterization, and they represent a 
selected subset of the general population. The results from 
the 10 “normal” patients in this study are applicable to 
patients who consult physicians for chest pain, and should 
be useful in discriminating those with and without significant 
coronary atherosclerosis with a high specificity. It may not 
be possible to generalize the results to apply to other normal 
subjects without chest pain or to all patients referred for 
exercise testing rather than coronary angiography. How- 
ever, our normal patients had no coronary atherosclerotic 
narrowings that exceeded 30% luminal reduction. Their 
responses may actually be similar to those of other selected 
normal subjects, but these data are not available. 
Because we selected patients without prior Q wave myo- 
cardial infarction, patients were unlikely to have had wall 
motion abnormalities at rest. The latter selection criterion 
optimized the sensitivity of both exercise and dipyridamole 
ventriculography because new wall motion abnormalities 
would be more easily detected than in a group of patients with 
prior extensive infarction and diffuse hypokinesia. If exercise 
or dipyridamole ventriculography were applied in a more 
general group of patients including those with wall motion 
abnormalities at rest, additional small changes might be 
missed, thereby decreasing the sensitivity of these tests. 
Mowever, this would not reduce the specificity. 
Dipyridamole dosage. We employed a higher dose of 
dipyridamole than is used in standard dipyridamole thallium 
testing, but somewhat lower than that used by Picano et al. 
(17) for echocardiography. Although more side effects might 
have occurred than with lower doses, they were usually mild 
and well tolerated. Because higher doses can increase the 
sensitivity of dipyridamole testing without altering the spec- 
ificity (IS), this larger dosage may be advantageous. 
Imaging technique. Two view analysis (anterior and left 
anterior oblique) provides significantly more information 
than does analysis using a single view (32). For future 
studies, we recommend adding further oblique projections 
such as 70” left anterior oblique, left lateral or 30” left 
posterior oblique to improve the sensitivity for detecting 
right coronary artery lesions (36). 
On the basis of the higher rate-pressure product as an 
index of oxygen demand (4), exercise is probably a stronger 
stimulus for ischemia than is dipyridamole. Indeed, we 
found greater wall motion abnormalities during exercise than 
after infusion of dipyridamole. However, an advantage of 
dioyridamole imaging is that the images appear sharper, in 
get. -al, than during exercise, because of the blurring effects 
of slight chest movement and deeper ventilation with exer- 
cise. A further potential advantage is the ability to acquire 
multiple images after dipyridamole infusion more easily than 
during exercise ventriculography. 
Theoretically, dipyridamole echocardiography might be a 
better test than radionuclide imaging. However, in ~20% of 
patients it is difficult to obtain an adequate echocardiogram 
(15,16,18,19). Also, general image quality and the visualiza- 
tion of regional wall motion depend heavily on the technician 
or physician performing the test. Conversely, excellent 
quality radionuclide images may be obtained in virtually all 
patients, along with quantitative rather than qualitative 
ejection fraction data. 
Conclusions. This study demonstrated that radionuclide 
ventriculography using pharmacologic coronary vasodilation 
at rest with dipyridamole compared favorably with exercise 
ventriculography for detecting both significant and severe 
coronary atherosclerosis by means of abnormal ventricular 
function. Abnormal ventricular function (reduced ejection 
fraction or abnormal regional wall motion) is a highly specific 
indicator of ischemia, in contrast to heterogeneous distribu- 
tion of the isotope thallium, which demonstrates flow differ- 
ences but not necessarily ischemia. Receiver operating char- 
acteristic analysis allowed the selection of decision criteria 
that produced “optimal” sensitivity and specificity for both 
dipyridamole and exercise ventriculography. We conclude 
that the dipyridamole technique provides a useful alternative 
to exercise ventriculography in the diagnosis of coronary 
artery disease in those patients who have limited exercise 
tolerance or in whom a very specific indictor of myocardial 
ischemia is desired. 
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